NYAS Conferences
New York Academy of Sciences
left end
Search
divider divider feedback right end
Annals of the New York Academy of Sciences Annals of the New York Academy of Sciences login

Main

Browse Volumes

Forthcoming Volumes

Annals PrePrints

Annals Extra

E-mail Alerts

Subscriptions & Orders

New Proposals

Author Guidelines

About Annals

Help

Get free Annals volume as a NYAS member: http://www.nyas.org/annalsreaderhw
Issue 1029 coverOral Tolerance: New Insights and Prospects for Clinical Application Volume 1029 published December 2004
Ann. N.Y. Acad. Sci. 1029: 1–8 (2004). doi: 10.1196/annals.1309.001
Copyright © 2004 by the New York Academy of Sciences
description | purchase volume purchase this volume

This Volume
Table of Contents
Description
This Article
Full Text
Full Text (PDF)
Services
Similar articles in this journal
Alert me to new issues of the journal
Download to citation manager
Citing Articles
Citing Articles via HighWire
Citing Articles via Google Scholar
Google Scholar
Articles by MOWAT, A. McI.
Articles by CHIRDO, F.
Search for Related Content
PubMed
Articles by MOWAT, A. McI.
Articles by CHIRDO, F.
Oral Tolerance: Overview and Historical Perspectives

ALLAN McI. MOWAT, LUCY A. PARKER, HELEN BEACOCK-SHARP, Owain R. Millington AND FERNANDO CHIRDO

Department of Immunology and Bacteriology, University of Glasgow, Western Infirmary, Glasgow, Scotland

Address for correspondence: Allan McI. Mowat, Department of Immunology and Bacteriology, University of Glasgow, Western Infirmary, Glasgow, Scotland. Voice: +44-141-2112728; fax: +44-141-3373217. a.m.mowat{at}clinmed.gla.ac.uk

ABSTRACT

Oral tolerance was first detailed almost 100 years ago, and since then, it has been shown repeatedly that feeding a wide variety of nonpathogenic antigens can inhibit subsequent systemic immune responses. All systemic immune responses are susceptible, but the degree and scope of the suppression depends on the nature and dose of the fed antigen. Oral tolerance has been described in most mammals, including humans, and it may be the homeostatic mechanism that prevents hypersensitivity to food antigens, as is found in celiac disease. A similar process may prevent the aberrant immune responses to commensal bacteria that occur in inflammatory bowel disease. The ability of oral tolerance to modulate experimental models of autoimmune and inflammatory disease has led to clinical trials in such diseases as rheumatoid arthritis, multiple sclerosis, and type I diabetes, with only variable success. Despite intense research, the exact mechanisms responsible for the systemic tolerance and the reasons why tolerance is the default response to many fed antigens remain controversial. Early studies suggested that CD8+ "suppressor" T cells were important, but it is now accepted that it may involve either anergy/deletion of CD4+ T cells, or the induction of regulatory CD4+ T cells that produce IL-10 and/or TGFß. There may also be a role for CD4+ CD25+ Treg, but how and when all these different mechanisms operate is still unclear. The ability of fed antigens to induce tolerance probably reflects their uptake by "quiescent" antigen-presenting cells in the intestine, with presentation to specific CD4+ T cells in the absence of costimulation, or with the involvement of inhibitory costimulatory molecules. Dendritic cells in the Peyer's patches or mucosal lamina propria are the most likely APCs involved, but it remains to be determined exactly where these interactions occur and what the precise nature of the relevant dendritic cells is.

Key Words: systemic immune response • celiac disease • Crohn's disease • experimental autoimmune encephalomyelitis • antigen-presenting cells • intestine




This article has been cited by other articles:


Home page
Am. J. Physiol. Gastrointest. Liver Physiol.Home page
Y. Tu and M. H. Perdue
CD23-mediated transport of IgE/immune complexes across human intestinal epithelium: role of p38 MAPK.
Am J Physiol Gastrointest Liver Physiol, September 1, 2006; 291(3): G532 - G538.
[Abstract] [Full Text] [PDF]


Home page
J. Dent. Res.Home page
C.W. Cutler and R. Jotwani
Dendritic cells at the oral mucosal interface.
J. Dent. Res., August 1, 2006; 85(8): 678 - 689.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. Sakai, H. Akiyama, Y. Sato, Y. Yoshioka, R. J. Linhardt, Y. Goda, T. Maitani, and T. Toida
Chondroitin Sulfate Intake Inhibits the IgE-mediated Allergic Response by Down-regulating Th2 Responses in Mice
J. Biol. Chem., July 21, 2006; 281(29): 19872 - 19880.
[Abstract] [Full Text] [PDF]


Home page
J. Exp. Med.Home page
T. Worbs, U. Bode, S. Yan, M. W. Hoffmann, G. Hintzen, G. Bernhardt, R. Forster, and O. Pabst
Oral tolerance originates in the intestinal immune system and relies on antigen carriage by dendritic cells
J. Exp. Med., March 20, 2006; 203(3): 519 - 527.
[Abstract] [Full Text] [PDF]


Home page
J. Exp. Med.Home page
I. Klein and I. N. Crispe
Complete differentiation of CD8+ T cells activated locally within the transplanted liver
J. Exp. Med., February 21, 2006; 203(2): 437 - 447.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
M. Rimoldi, M. Chieppa, P. Larghi, M. Vulcano, P. Allavena, and M. Rescigno
Monocyte-derived dendritic cells activated by bacteria or by bacteria-stimulated epithelial cells are functionally different
Blood, October 15, 2005; 106(8): 2818 - 2826.
[Abstract] [Full Text] [PDF]



footerLeft footerRight